Related Experiment Videos
LASIK interface keratitis: epidemiology, diagnosis and care
1Department of Ophthalmology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York 10467, USA. dgritz@montefiore.org
Current Opinion in Ophthalmology
|May 4, 2011
Summary
Diffuse lamellar keratitis (DLK), a common complication after laser in-situ keratomileusis (LASIK), presents diagnostic challenges. Early diagnosis and steroid treatment generally lead to good visual outcomes for this LASIK complication.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Refractive Surgery
Background:
- Diffuse lamellar keratitis (DLK) is a frequent interface complication following laser in-situ keratomileusis (LASIK).
- Distinguishing DLK from infectious keratitis is crucial due to differing treatment protocols.
- DLK diagnosis can be challenging, necessitating a thorough understanding of its characteristics.
Purpose of the Study:
- To review the current knowledge on the epidemiology, diagnosis, and treatment of diffuse lamellar keratitis (DLK).
- To assess the challenges in differentiating DLK from other interface complications after LASIK.
- To provide an overview of management strategies for DLK.
Main Methods:
- Literature review of studies on diffuse lamellar keratitis (DLK) post-LASIK.
- Analysis of epidemiological data, diagnostic criteria, and treatment outcomes for DLK.
- Synthesis of current understanding regarding risk factors and clinical presentation of DLK.
Main Results:
- DLK can manifest in the immediate postoperative period or as late-onset cases, sometimes occurring in outbreaks linked to exogenous factors.
- Late-onset DLK is often associated with specific inciting factors, with increasing reports of later onset over time.
- Good visual outcomes are typical for DLK when diagnosed promptly and treated effectively with corticosteroids and potential interface irrigation.
Conclusions:
- Diffuse lamellar keratitis (DLK) is a well-documented complication of LASIK surgery.
- Established risk factors and treatment algorithms exist, but further research is needed.
- Evidence-based treatment advancements for DLK will benefit patient care and outcomes.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...